184 related articles for article (PubMed ID: 32580247)
41. COX‑2 promotes epithelial‑mesenchymal transition and migration in osteosarcoma MG‑63 cells via PI3K/AKT/NF‑κB signaling.
Zhang X; Qu P; Zhao H; Zhao T; Cao N
Mol Med Rep; 2019 Oct; 20(4):3811-3819. PubMed ID: 31485669
[TBL] [Abstract][Full Text] [Related]
42.
Luo Y; Tao H; Jin L; Xiang W; Guo W
Cancer Biother Radiopharm; 2020 Feb; 35(1):58-65. PubMed ID: 31724892
[No Abstract] [Full Text] [Related]
43. Inhibition of fatty acid synthase suppresses U-2 OS cell invasion and migration via downregulating the activity of HER2/PI3K/AKT signaling pathway in vitro.
Wang TF; Wang H; Peng AF; Luo QF; Liu ZL; Zhou RP; Gao S; Zhou Y; Chen WZ
Biochem Biophys Res Commun; 2013 Oct; 440(2):229-34. PubMed ID: 24041695
[TBL] [Abstract][Full Text] [Related]
44. Tomatidine Represses Invasion and Migration of Human Osteosarcoma U2OS and HOS Cells by Suppression of Presenilin 1 and c-Raf-MEK-ERK Pathway.
Hsieh MH; Yang JS; Lin RC; Hsieh YH; Yang SF; Chang HR; Lu KH
Molecules; 2020 Jan; 25(2):. PubMed ID: 31941156
[TBL] [Abstract][Full Text] [Related]
45. Calycosin, a Phytoestrogen Isoflavone, Induces Apoptosis of Estrogen Receptor-Positive MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Sun H; Yin M; Qian W; Yin H
Med Sci Monit; 2018 Sep; 24():6178-6186. PubMed ID: 30182951
[TBL] [Abstract][Full Text] [Related]
46. Carboxypeptidase E-ΔN promotes migration, invasiveness, and epithelial-mesenchymal transition of human osteosarcoma cells via the Wnt-β-catenin pathway.
Fan S; Gao X; Chen P; Li X
Biochem Cell Biol; 2019 Aug; 97(4):446-453. PubMed ID: 30508384
[TBL] [Abstract][Full Text] [Related]
47. TWIST1-mediated transcriptional activation of PDGFRβ in breast cancer stem cells promotes tumorigenesis and metastasis.
Yeeravalli R; Kaushik K; Das A
Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166141. PubMed ID: 33845139
[TBL] [Abstract][Full Text] [Related]
48. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
Liu ZB; Wang JA; Lv RQ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
[TBL] [Abstract][Full Text] [Related]
49. PDGF-BB/PDGFRβ induces tumour angiogenesis via enhancing PKM2 mediated by the PI3K/AKT pathway in Wilms' tumour.
Sang BT; Wang CD; Liu X; Guo JQ; Lai JY; Wu XM
Med Oncol; 2023 Jul; 40(8):240. PubMed ID: 37442847
[TBL] [Abstract][Full Text] [Related]
50. The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer.
Forte L; Turdo F; Ghirelli C; Aiello P; Casalini P; Iorio MV; D'Ippolito E; Gasparini P; Agresti R; Belmonte B; Sozzi G; Sfondrini L; Tagliabue E; Campiglio M; Bianchi F
BMC Cancer; 2018 May; 18(1):586. PubMed ID: 29792166
[TBL] [Abstract][Full Text] [Related]
51. Akt- and Erk-mediated regulation of proliferation and differentiation during PDGFRβ-induced MSC self-renewal.
Gharibi B; Ghuman MS; Hughes FJ
J Cell Mol Med; 2012 Nov; 16(11):2789-801. PubMed ID: 22805337
[TBL] [Abstract][Full Text] [Related]
52. [The role of CD44 in the proliferation, adhesiveness and invasiveness of osteosarcoma cell lines].
Peng TS; Qiu JS; Li Z; Zhang M; Liang HZ
Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):362-6. PubMed ID: 16185508
[TBL] [Abstract][Full Text] [Related]
53. PKG II inhibits PDGF-BB triggered biological activities by phosphorylating PDGFRβ in gastric cancer cells.
Wang Y; Appiah-Kubi K; Lan T; Wu M; Pang J; Qian H; Tao Y; Jiang L; Wu Y; Chen Y
Cell Biol Int; 2018 Sep; 42(10):1358-1369. PubMed ID: 29935031
[TBL] [Abstract][Full Text] [Related]
54. The expression and function of miRNA-106 in pediatric osteosarcoma.
Xu M; Zhang YY; Wang HF; Yang GS
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):715-722. PubMed ID: 28272712
[TBL] [Abstract][Full Text] [Related]
55. Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma.
Kubo T; Piperdi S; Rosenblum J; Antonescu CR; Chen W; Kim HS; Huvos AG; Sowers R; Meyers PA; Healey JH; Gorlick R
Cancer; 2008 May; 112(10):2119-29. PubMed ID: 18338812
[TBL] [Abstract][Full Text] [Related]
56. Effects of MicroRNA-206 on Osteosarcoma Cell Proliferation, Apoptosis, Migration and Invasion by Targeting ANXA2 Through the AKT Signaling Pathway.
Pan BL; Tong ZW; Wu L; Pan L; Li JE; Huang YG; Li SD; Du SX; Li XD
Cell Physiol Biochem; 2018; 45(4):1410-1422. PubMed ID: 29462818
[TBL] [Abstract][Full Text] [Related]
57. Simvastatin preparations promote PDGF-BB secretion to repair LPS-induced endothelial injury through the PDGFRβ/PI3K/Akt/IQGAP1 signalling pathway.
Zheng X; Zhang W; Wang Z
J Cell Mol Med; 2019 Dec; 23(12):8314-8327. PubMed ID: 31576676
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA-129-5p suppresses cell proliferation, migration and invasion via targeting ROCK1 in osteosarcoma.
Han C; Wang W
Mol Med Rep; 2018 Mar; 17(3):4777-4784. PubMed ID: 29328417
[TBL] [Abstract][Full Text] [Related]
59. The Effects of Interleukin-33 (IL-33) on Osteosarcoma Cell Viability, Apoptosis, and Epithelial-Mesenchymal Transition are Mediated Through the PI3K/AKT Pathway.
Wang S; Zhao G; Zhao S; Qiao Y; Yang H
Med Sci Monit; 2020 Apr; 26():e920766. PubMed ID: 32312946
[TBL] [Abstract][Full Text] [Related]
60. Chalcone Derivatives 4'-Amino-1-Naphthyl-Chalcone (D14) and 4'-Amino-4-Methyl-1-Naphthyl-Chalcone (D15) Suppress Migration and Invasion of Osteosarcoma Cells Mediated by p53 Regulating EMT-Related Genes.
Seba V; Silva G; Santos MBD; Baek SJ; França SC; Fachin AL; Regasini LO; Marins M
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
